EagleClaw Capital Managment LLC Has $8.24 Million Stock Position in CME Group Inc. (NASDAQ:CME)

EagleClaw Capital Managment LLC lowered its stake in CME Group Inc. (NASDAQ:CME) by 0.3% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 37,330 shares of the financial services provider’s stock after selling 110 shares during the quarter. CME Group comprises approximately 1.4% of EagleClaw Capital Managment LLC’s holdings, making the stock its 24th largest holding. EagleClaw Capital Managment LLC’s holdings in CME Group were worth $8,237,000 as of its most recent SEC filing.

A number of other large investors also recently made changes to their positions in the stock. Capital International Investors lifted its stake in shares of CME Group by 24.1% in the 1st quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock valued at $3,403,557,000 after purchasing an additional 3,069,806 shares during the period. Ameriprise Financial Inc. lifted its holdings in CME Group by 11.3% during the second quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock worth $1,038,676,000 after acquiring an additional 537,758 shares in the last quarter. GUARDCAP ASSET MANAGEMENT Ltd grew its stake in CME Group by 1.1% in the first quarter. GUARDCAP ASSET MANAGEMENT Ltd now owns 4,009,068 shares of the financial services provider’s stock valued at $863,112,000 after acquiring an additional 43,293 shares during the period. Raymond James & Associates increased its holdings in shares of CME Group by 3.2% in the second quarter. Raymond James & Associates now owns 3,029,145 shares of the financial services provider’s stock worth $595,530,000 after acquiring an additional 94,302 shares in the last quarter. Finally, Legal & General Group Plc raised its position in shares of CME Group by 6.6% during the second quarter. Legal & General Group Plc now owns 2,835,075 shares of the financial services provider’s stock worth $557,371,000 after purchasing an additional 176,004 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the company. TD Cowen began coverage on CME Group in a research report on Thursday, September 26th. They issued a “hold” rating and a $221.00 price objective for the company. JPMorgan Chase & Co. increased their price objective on shares of CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a research report on Thursday, July 25th. Keefe, Bruyette & Woods boosted their price objective on shares of CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a research report on Thursday, July 25th. Citigroup lifted their price target on CME Group from $250.00 to $255.00 and gave the company a “buy” rating in a research note on Thursday, October 24th. Finally, Royal Bank of Canada reaffirmed a “sector perform” rating and set a $235.00 price objective on shares of CME Group in a research report on Thursday, October 24th. Four investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $224.47.

Insiders Place Their Bets

In other news, Director Timothy S. Bitsberger sold 1,000 shares of the business’s stock in a transaction dated Wednesday, October 30th. The shares were sold at an average price of $226.96, for a total value of $226,960.00. Following the completion of the sale, the director now owns 10,589 shares of the company’s stock, valued at approximately $2,403,279.44. The trade was a 8.63 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Timothy Francis Mccourt sold 1,374 shares of the business’s stock in a transaction dated Monday, October 28th. The shares were sold at an average price of $227.12, for a total transaction of $312,062.88. Following the completion of the sale, the insider now directly owns 7,275 shares of the company’s stock, valued at approximately $1,652,298. The trade was a 15.89 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 15,621 shares of company stock valued at $3,441,063 over the last ninety days. 0.30% of the stock is currently owned by company insiders.

CME Group Stock Up 0.1 %

CME traded up $0.21 during trading on Wednesday, reaching $229.87. 66,229 shares of the stock were exchanged, compared to its average volume of 1,903,918. The stock has a market cap of $82.84 billion, a P/E ratio of 24.15, a price-to-earnings-growth ratio of 5.20 and a beta of 0.55. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $230.74. The stock’s 50 day moving average price is $223.02 and its two-hundred day moving average price is $210.69. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, topping analysts’ consensus estimates of $2.65 by $0.03. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The firm had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.59 billion. During the same period in the previous year, the business posted $2.25 earnings per share. The company’s revenue for the quarter was up 18.4% compared to the same quarter last year. Equities analysts expect that CME Group Inc. will post 10.22 EPS for the current year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Monday, December 9th will be given a dividend of $1.15 per share. The ex-dividend date is Monday, December 9th. This represents a $4.60 dividend on an annualized basis and a yield of 2.00%. CME Group’s dividend payout ratio (DPR) is 48.37%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.